Pharmaceutical ingredients, including an ampoule active agent and B selected from formaldehyde, fenforine and Bucha rice, a serum reactive compound selected from serotonin, cyanuric chloride, serotonin sulfate creatinina, 5-hydroxysuccinic acid and other substances, and substances for the treatment of metabolism and obesity.
Pharmaceutical composition comprising a First Agent Activating Kinase (AMPK) and a Second Agent that possesses or maintains serotonin activity； a method for treating a disease or condition such as metabolic syndrome, diabetes, obesity, cancer, Parkinson's disease, sleep apnea, in Among other.SE DESCRIBE UNA COMPOSICIÓN FARMACÉUTICA QUE COMPRENDE UN ACTIVADOR DE AMPK SELECCIONADO DE METFORMINA, FENFORMINA Y BUFORMINA Y UN COMPUESTO SEROTONINÉRGICO SELECCIONADO DE SEROTONINA, SULFATO DE SEROTONINA, COMPLEJO SULFATO SEROTONINA-CREATININA, CLORHIDRATO DE SEROTONINA, MELATONINA, ÁCIDO 5-HIDROXIINDOLACÉTICO, UNA SAL DE ÁCIDO 5-HIDROXIINDOLACÉTICO, COMPLEJO SULFATO DE MELATONINA-CREATININA Y COMPLEJO SULFATO DE ÁCIDO 5-HIDROXIINDOLACÉTICO-CREATININA Y SU USO PARA TRATAR EL SÍNDROME METABÓLICO Y OBESIDAD.
